diabetes

MannKind Announces Late-Breaking Data Reinforcing Faster Onset and Shorter Duration of Action Compared to Mealtime Insulins
Yahoo
Sun, 06/12/16 - 09:59 pm
MannKind
Afrezza
diabetes
inhaled insulin
AstraZeneca Presents New Data from Multiple Studies on the Effect of BYDUREON on Glucose Fluctuations in Patients with Type 2 Diabetes
Yahoo
Sun, 06/12/16 - 12:29 pm
AstraZeneca
Bydureon
clinical trials
diabetes
type 2 diabetes
Merck, Pfizer Double Size of Diabetes Drug Study to Catch Rivals
Bloomberg
Sun, 06/12/16 - 12:25 pm
Merck
Pfizer
diabetes
clinical trials
ertugliflozin
Januvia
J&J preparing to launch a new mealtime insulin delivery patch
Bizjournals.com
Sun, 06/12/16 - 12:24 pm
JNJ
diabetes
insulin
OneTouch Via
Top Equity Manager Still Believes In MannKind
Forbes
Wed, 06/1/16 - 10:11 am
MannKind
Afrezza
inhaled insulin
diabetes
Sanofi Wins FDA Panel’s Backing for Once-Daily Diabetes Combo
Bloomberg
Wed, 05/25/16 - 09:35 pm
Sanofi
FDA
advisory panels
diabetes
lixisenatide
Lantus
In unanimous vote, FDA panel recommends Novo diabetes drug
BioPharma Dive
Wed, 05/25/16 - 09:28 pm
FDA
advisory panels
Novo Nordisk
diabetes
IDegLira
Medtronic And Qualcomm To Develop Continuous Glucose Monitoring System
Yahoo/Benzinga
Wed, 05/25/16 - 09:22 pm
Medtronic
Qualcomm
devices
diabetes
blood glucose monitoring
Sanofi Is Shuffling Its Exec Roster Amid Continued Struggles
Fortune
Tue, 05/24/16 - 12:10 am
Sanofi
diabetes
Cardiovascular
Sanofi shakes up management team as top diabetes exec departs, consumer business expands
Fierce Pharma
Mon, 05/23/16 - 12:23 pm
Sanofi
diabetes
Ahead of key panel vote, FDA staff raises concerns over Novo diabetes drug
BioPharma Dive
Mon, 05/23/16 - 10:40 am
FDA
advisory panels
Novo Nordisk
diabetes
IDegLira
Oramed's oral insulin shines in mid-stage trials
BioPharma Dive
Mon, 05/23/16 - 10:37 am
Oramed
clinical trials
insulin
diabetes
ORMD-0181
FDA Staff Questions Usefulness of Sanofi’s Diabetes Drug Combo
Bloomberg
Mon, 05/23/16 - 10:16 am
FDA
Sanofi
diabetes
clinical trials
Lantus
Lyxumia
FDA staffers air concerns over Novo's Victoza-Tresiba combo
Fierce Pharma
Sat, 05/21/16 - 12:40 pm
FDA
Novo Nordisk
diabetes
Xultophy
Tresiba
Victoza
Januvia and Janumet: Merck’s Blockbuster Diabetes Drugs
Yahoo/Market Realist
Thu, 05/12/16 - 04:48 pm
Merck
diabetes
Januvia
Janumet
Diabetes 'Unicorn' Intarcia Hits Major Milestone
Fortune
Fri, 05/6/16 - 10:33 am
Intarcia
diabetes
type 2 diabetes
IPOs
ITCA 650
Interview – Boehringer’s new look aims to boost innovation
EP Vantage
Wed, 04/27/16 - 02:41 pm
R&D
Boehringer Ingelheim
biotech
diabetes
Boehringer sees turbocharged diabetes unit driving future growth
Fierce Pharma
Mon, 04/25/16 - 10:06 am
Boehringer Ingelheim
diabetes
Eli Lilly’s Jardiance Can be a Threat to Novartis’ Entresto
Bidness, ETC
Wed, 04/20/16 - 09:46 pm
Eli Lilly
Jardiance
Novartis
Entresto
Boehringer Ingelheim
diabetes
heart failure
Novo Nordisk: 'Holy Grail' Diabetes Pill Has Big Advantages
Seeking Alpha
Wed, 04/20/16 - 09:50 am
Novo Nordisk
diabetes
Victoza

Pages